Hapbee (HAPB) to Commence Trading on the TSX Venture Exchange.
VANCOUVER, BC, Oct. 28, 2020 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) ("Hapbee" or the "Company"), a wellness technology company developing the...
It’s Biotech Season! Five Deals to Raise $611 Million.
The Biotech IPO Queue Grows Longer as Five More Companies File (Xconomy)
Alkero Therapeutics, $86 Million.Prevail Therapeutics, $100...
Beyonce Tells Uber “Pay me in Stock!”
We all know Beyoncé is brilliant, but this move she made in 2015 may be the absolute ultimate in future planning. Four...
Hapbee (HAPB) Soars 136% the First Day of Trading!
LIVE QUOTE
Subscribe here for upcoming report.
Hapbee Technologies (HAPB): Updates and News Archive.
Recent Headlines
UPDATED CONTINUOUSLY.
June 4, 2021: Hapbee (HAPBF) Selects Accomplished...
How Uber Changed Transportation Forever.
Uber’s stunning journey to a $90 billion IPO changed transportation forever (Quartz).
Uber redefined how we think about...
Telehealth: CB Scientific (CBSC) Acquires Prevent Health Care International Corp.
CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business.
Orchestra BioMed™ Announces Completion of $41 Million Financing.
November 15, 2018
Capital proceeds to support late-stage clinical development of lead cardiovascular product candidates for artery disease and...
Hapbee Corporate Presentation. Private.
FOR INSTITUTIONAL USE ONLY.
Redefy Corporation* (RDCO) Announces Up to $6 Million Private Securities Offering.
- Rule 506(c) Offering Solely to Accredited Investors -
DENVER, June 05, 2019 (GLOBE NEWSWIRE) -- Redefy Corporation* (a/k/a...
Latest article
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
